The Dow Jones popped this morning on news that a drug from Gilead Sciences (NASDAQ: GILD) showed some effectiveness in treating patients with coronavirus.
Shares of the drug company surged 16% after the bell on a report from a Chicago hospital that showed progress from Remdesivir.
Start the conversation